000285040 001__ 285040
000285040 005__ 20260209101311.0
000285040 0247_ $$2doi$$a10.1038/s41531-025-01239-x
000285040 0247_ $$2pmid$$apmid:41545406
000285040 0247_ $$2pmc$$apmc:PMC12847943
000285040 037__ $$aDZNE-2026-00164
000285040 041__ $$aEnglish
000285040 082__ $$a610
000285040 1001_ $$0P:(DE-HGF)0$$aSchmidt, M. Y.$$b0
000285040 245__ $$aUnraveling the intersection of aging and Parkinson's disease: a collaborative roadmap for advancing research models.
000285040 260__ $$a[London]$$bSpringer Nature$$c2026
000285040 3367_ $$2DRIVER$$aarticle
000285040 3367_ $$2DataCite$$aOutput Types/Journal article
000285040 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1770628275_24272$$xReview Article
000285040 3367_ $$2BibTeX$$aARTICLE
000285040 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000285040 3367_ $$00$$2EndNote$$aJournal Article
000285040 520__ $$aAging is the most significant risk factor for Parkinson's disease (PD), yet its role remains underexplored. The International Network for Parkinson's Disease Modelling and Aging (PD-AGE), funded by the Michael J. Fox Foundation, was established to address these challenges. Through collaborative efforts, the PD-AGE mouse-model working group developed a roadmap to prioritize mouse models, reach consensus on experimental approaches, and standardize protocols to investigate the intersection of aging and PD.
000285040 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000285040 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000285040 7001_ $$aCuervo, A. M.$$b1
000285040 7001_ $$aDouble, K. L.$$b2
000285040 7001_ $$0P:(DE-2719)2289209$$aEhninger, D.$$b3$$udzne
000285040 7001_ $$aGoldberg, M. S.$$b4
000285040 7001_ $$aHarvey, K.$$b5
000285040 7001_ $$aHoeijmakers, J. H. J.$$b6
000285040 7001_ $$aLuk, K. C.$$b7
000285040 7001_ $$aMastroberardino, P. G.$$b8
000285040 7001_ $$aMoore, D. J.$$b9
000285040 7001_ $$aNiedernhofer, L. J.$$b10
000285040 7001_ $$aTrudeau, L É$$b11
000285040 7001_ $$aJurk, D.$$b12
000285040 7001_ $$aAndersen, J. K.$$b13
000285040 7001_ $$aBellantuono, I.$$b14
000285040 773__ $$0PERI:(DE-600)2819218-7$$a10.1038/s41531-025-01239-x$$gVol. 12, no. 1, p. 28$$n1$$p28$$tnpj Parkinson's Disease$$v12$$x2373-8057$$y2026
000285040 8564_ $$uhttps://pub.dzne.de/record/285040/files/DZNE-2026-00164.pdf$$yRestricted
000285040 8564_ $$uhttps://pub.dzne.de/record/285040/files/DZNE-2026-00164.pdf?subformat=pdfa$$xpdfa$$yRestricted
000285040 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2289209$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000285040 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000285040 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNPJ PARKINSONS DIS : 2022$$d2024-12-11
000285040 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-11
000285040 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-11
000285040 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:43:48Z
000285040 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:43:48Z
000285040 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-10T15:43:48Z
000285040 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2024-04-10T15:43:48Z
000285040 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-11
000285040 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-11
000285040 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-11
000285040 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-11
000285040 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-11
000285040 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNPJ PARKINSONS DIS : 2022$$d2024-12-11
000285040 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-11
000285040 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-11
000285040 9201_ $$0I:(DE-2719)1013005$$kAG Ehninger$$lTranslational Biogerontology$$x0
000285040 980__ $$ajournal
000285040 980__ $$aEDITORS
000285040 980__ $$aVDBINPRINT
000285040 980__ $$aI:(DE-2719)1013005
000285040 980__ $$aUNRESTRICTED